These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22052269)

  • 1. Management of impending necrosis associated with soft tissue filler injections.
    Dayan SH; Arkins JP; Mathison CC
    J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase.
    Hirsch RJ; Lupo M; Cohen JL; Duffy D
    J Drugs Dermatol; 2007 Mar; 6(3):325-8. PubMed ID: 17373195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature.
    Kassir R; Kolluru A; Kassir M
    J Cosmet Dermatol; 2011 Sep; 10(3):224-31. PubMed ID: 21896135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.
    Kim DW; Yoon ES; Ji YH; Park SH; Lee BI; Dhong ES
    J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1590-5. PubMed ID: 21807574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
    Hirsch RJ; Brody HJ; Carruthers JD
    J Cosmet Laser Ther; 2007 Sep; 9(3):182-5. PubMed ID: 17763028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment.
    Cassuto D; Sundaram H
    Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):48S-58S. PubMed ID: 24077011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroglycerin, or Not, When Treating Impending Filler Necrosis.
    Carley SK; Kraus CN; Cohen JL
    Dermatol Surg; 2020 Jan; 46(1):31-40. PubMed ID: 31356437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.
    Andre P; Fléchet ML
    J Cosmet Dermatol; 2008 Jun; 7(2):136-8. PubMed ID: 18482018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-filler vascular occlusion: a cautionary tale and emphasis for early intervention.
    McGuire LK; Hale EK; Godwin LS
    J Drugs Dermatol; 2013 Oct; 12(10):1181-3. PubMed ID: 24085057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal Filler-Induced Vascular Occlusion Successfully Treated With Tadalafil, Hyaluronidase, and Aspirin.
    Chuchvara N; Alamgir M; John AM; Rao B
    Dermatol Surg; 2021 Aug; 47(8):1160-1162. PubMed ID: 33867474
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with hyaluronic acid-filler complications.
    Park TH; Seo SW; Kim JK; Chang CH
    J Plast Reconstr Aesthet Surg; 2011 Jul; 64(7):892-6. PubMed ID: 21310674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroglycerin: a review of its use in the treatment of vascular occlusion after soft tissue augmentation.
    Kleydman K; Cohen JL; Marmur E
    Dermatol Surg; 2012 Dec; 38(12):1889-97. PubMed ID: 23205544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft Tissue Dermal Filler-Associated Necrosis and Impending Necrosis: A Systematic Review of the Literature.
    Rentfro K; Clarey D; Glenn EJ; Sulewski R; Wysong A
    Dermatol Surg; 2022 Oct; 48(10):1051-1056. PubMed ID: 36129182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose of Hyaluronidase to treat over correction by HA filler--a case report.
    Menon H; Thomas M; D'silva J
    J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):e416-7. PubMed ID: 20133216
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications of soft tissue augmentation.
    Hirsch RJ; Stier M
    J Drugs Dermatol; 2008 Sep; 7(9):841-5. PubMed ID: 19112797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.
    Hirsch RJ; Cohen JL; Carruthers JD
    Dermatol Surg; 2007 Mar; 33(3):357-60. PubMed ID: 17338697
    [No Abstract]   [Full Text] [Related]  

  • 19. Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.
    Chesnut C
    Dermatol Surg; 2018 Mar; 44(3):435-437. PubMed ID: 28877147
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Outcomes of Impending Nasal Skin Necrosis Related to Nose and Nasolabial Fold Augmentation with Hyaluronic Acid Fillers.
    Sun ZS; Zhu GZ; Wang HB; Xu X; Cai B; Zeng L; Yang JQ; Luo SK
    Plast Reconstr Surg; 2015 Oct; 136(4):434e-441e. PubMed ID: 26397262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.